Yuhuan Wang

This inventor holds 9 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2014-2023.

USPTO Granted Patents = 9 (Patent Applications = 2)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 12(Granted Patents)

Location History:

Lilburn, GA (US) (2014 - 2018)
Liburn, GA (US) (2019 - 2023)

Company Filing History:

9 out of 3,688

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

Years Active: 2014-2023

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11786589 - Human rotavirus strains and vaccines (2023-10-17),

2. 11759513 - Human rotavirus G9P[6] strain and use as a vaccine (2023-09-19),

3. 11185581 - Human rotavirus G9P[6] strain and use as a vaccine (2021-11-30),

4. 11065327 - Human rotavirus strains and vaccines (2021-07-20),

5. 10548970 - Human rotavirus G9P[6] strain and use as a vaccine (2020-02-04),

6. 10500269 - Human rotavirus vaccine strains and diagnostics (2019-12-10),

7. 9974851 - Human rotavirus vaccine strains and diagnostics (2018-05-22),

8. 9498526 - Human rotavirus vaccine strains and diagnostics (2016-11-22),

9. 8822192 - Human rotavirus vaccine strains and diagnostics (2014-09-02),

Title: Yuhuan Wang: Innovator in Rotavirus Vaccines

Introduction

Yuhuan Wang is a prominent inventor based in Liburn, Georgia, known for his significant contributions to the field of immunology. With a total of nine patents to his name, Wang has focused his research on developing vaccines for human rotavirus, a leading cause of severe diarrhea in children.

Latest Patents

Wang's latest patents include innovative vaccine compositions aimed at immunizing subjects against rotavirus. One notable patent describes a vaccine composition that includes rotavirus strains CDC-9 and CDC-66, along with methods for inducing an immunological response through vaccination. Another patent highlights an attenuated G9P[6] rotavirus, which can be used in pharmaceutical compositions to induce protective immune responses, particularly in infants.

Career Highlights

Yuhuan Wang is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this esteemed institution has allowed him to contribute to vital research in vaccine development, focusing on enhancing public health through innovative solutions.

Collaborations

Wang has collaborated with notable colleagues in his field, including Baoming Jiang and Roger I Glass. These partnerships have facilitated advancements in vaccine research and development, furthering the impact of their collective work.

Conclusion

Yuhuan Wang's dedication to developing effective vaccines against rotavirus showcases his commitment to improving global health. His innovative patents and collaborations highlight the importance of research in combating infectious diseases.